Estimates of Insulin Out-of-Pocket Cap–Associated Prescription Satisfaction, Adherence, and Affordability Among Medicare Beneficiaries-Reference-Cited by-同舟云学术

Estimates of Insulin Out-of-Pocket Cap–Associated Prescription Satisfaction, Adherence, and Affordability Among Medicare Beneficiaries

Published:2023-01-13 Issue:1 Volume:6 Page:e2251208
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Li Minghui¹,Yuan Jing²,Lu Kevin³

Affiliation:

1. Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis

2. Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China

3. Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia

Abstract

This survey study examines the association of the Inflation Reduction Act of 2022 insulin out-of-pocket cap with prescription satisfaction, adherence, and affordability among Medicare beneficiaries and associated disparities.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2800403/li_2023_ld_220302_1672893083.74176.pdf

Reference5 articles.

1. Association of out-of-pocket spending with insulin adherence in Medicare Part D.;Trish;JAMA Netw Open,2021

2. Cost-related insulin underuse among patients with diabetes.;Herkert;JAMA Intern Med,2019

3. Reliability of new measures of cost-related medication nonadherence.;Pierre-Jacques;Med Care,2008

4. Estimation of the share of net expenditures on insulin captured by US manufacturers, wholesalers, pharmacy benefit managers, pharmacies, and health plans from 2014 to 2018.;Van Nuys;JAMA Health Forum,2021

5. White House. By the numbers: the Inflation Reduction Act. August 15, 2022. Accessed October 3, 2021. https://www.whitehouse.gov/briefing-room/statements-releases/2022/08/15/by-the-numbers-the-inflation-reduction-act/

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of machine learning in affordable and accessible insulin management for type 1 and 2 diabetes: A comprehensive review;Artificial Intelligence in Medicine;2024-05

2. Association of State Insulin Out-of-Pocket Caps With Insulin Cost-Sharing and Use Among Commercially Insured Patients With Diabetes;Annals of Internal Medicine;2024-04

3. National Volume-Based Procurement (NVBP) exclusively for insulin: towards affordable access in China and beyond;BMJ Global Health;2024-01

4. Stakeholder Perspectives of the Inflation Reduction Act’s (2022) Impact on Prescription Drugs: A Narrative Review;Pharmacy;2023-12-17

5. Affordability of Insulin for Non-Elderly Adults in the United States following $35 Monthly Out-of-Pocket Cap;Journal of General Internal Medicine;2023-11-20